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Drug dependence is a far-reaching problem that goes beyond the
individual to society at large. While a myriad of substances have addictive
properties, the scope of this review is limited to crack cocaine – how the brain,
specifically the mesolimbic dopamine system, is compromised by administration
of crack cocaine, physiological changes and the relevance of dopamine levels to
susceptibility to addiction.
Studies based on the use of behavior analysis tools including functional
analysis, positive and negative reinforcement, delayed discounting, contingency
management, stages of readiness, motivation for change, and determining
alternate behaviors as replacements for addictive behavior are included.
Participants in the primary studies were cocaine abusers who were attending
community treatment centers. Inclusion criteria varied by study but most required
a clean or negative urine result prior to the start of the study as well as an
assessment to determine extent of drug use and other baseline measurements.
The use of behavior analysis in providing treatment options is a viable alternative
for crack addicted individuals as shown by studies presented in this review.
Offering addiction professionals effective treatment programs such as
contingency management using voucher programs is viable but only if
i

communities are willing to provide the resources necessary to make these
alternative treatments available to paying and nonpaying clients.
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CHAPTER 1
INTRODUCTION

What is an addiction? What is the difference between substance abuse
and substance addiction? Why is an addiction so difficult to stop? What factors, if
any, come into play with addiction? Is addiction a disease or a learned behavior?
There are so many questions surrounding addiction, many of which are left
unanswered or answered without adequate scientific evidence, to the detriment
of the individuals struggling with a life-altering addiction.
To cover the myriad of substances abused by individuals would be beyond
the scope of this paper. Instead the focus is to address addiction to one illicit
substance, specifically crack cocaine. While similarities exist between various
substances, whether licit or illicit, and individuals may have more than one
addiction, for example to nicotine and alcohol in addition to crack cocaine, crack
cocaine is of particular interest due to its highly addictive properties.
Addiction Defined
Addiction or dependence on a drug is a chronic disorder
characterized by compulsive behavior to find and take the drug, loss of control to
limit intake of the drug, and emergence of a “negative emotional state” such as
anxiety or depression when the drug is unavailable (Koob, 2006, p. 25).
Progression from abuse to dependence does not always occur. Individuals may
never progress beyond risky consumption while others may go back and forth
between abstinence, excessive use and dependence. (Substance Abuse and
Mental Health Services Administration, 1999).
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Miller and Carroll (2006) identified variables that contribute to drug
abuse. These include “elevated rates of family discord, violence, health
problems, unemployment, poverty and financial problems, homelessness, crime,
injury, child behavior problems, child abuse and neglect, disability and a host of
psychological and mood problems” (Miller & Carroll, 2006, pp. 208-209). The
authors also recognized the pattern that leads to drug dependence. “No one sets
out to become addicted to drugs. It happens gradually, beginning with initial
experimentation, moving on to more frequent use, and so on (Miller & Carroll,
2006, p. 296). “There is no clear moment when a person ‘becomes’ dependent or
addicted. Instead, dependence emerges over time as the person’s life becomes
increasingly centered on drug use. The diagnostic criteria for classifying people
with ‘drug abuse’ and ‘drug dependence’ represent arbitrary cut points along a
gradual continuum (Miller & Carroll, 2006, p. 296).
There are a host of variables that lend themselves to a propensity
for addiction. Heredity, environment, including family and peers, cultural norms,
gender, and age are part of the mix that may play a part in an individual’s ability
to avoid becoming dependent on drugs or they may stack the deck against the
individual, making them more susceptible to the addictive properties of drugs.
These variables may be referenced in this discussion but are for the most part
beyond the scope of this review.
Properties of Crack Cocaine
One of the most potent stimulants, cocaine originates from coca
leaves which are grown primarily in the South American countries of Peru,
Ecuador and Columbia. The coca leaves have been smoked by the indigenous

3
people of these countries to alleviate the adversities of living at high altitudes and
to reduce fatigue (Kinsey et al., 2009).
As early as the 1880s, cocaine was used for medicinal purposes when it
was used as an anesthetic for eye, throat and nose surgeries to eliminate pain
and to constrict blood vessels to control bleeding. The powdered, hydrochloride
salt form of the drug can be snorted or dissolved in water and injected. When
snorted, cocaine powder is inhaled through the nose where it is absorbed into the
bloodstream through the nasal tissues. When injected, a needle is used to
release the drug directly into the bloodstream. Smoking involves inhaling cocaine
vapor or smoke into the lungs where absorption into the bloodstream is as rapid
as by injection. (Office of National Drug Control Policy, 2008).
Approximately 100 years after powder cocaine was first used, a derivative
became the drug of choice for many individuals in the 1980s and 1990s because
it was easy to obtain and relatively inexpensive to buy. The derivative was crack
cocaine, an addictive stimulant more powerful than cocaine in powdered form.
“Crack is cocaine that has been processed from cocaine hydrochloride to a free
base for smoking. It is processed with ammonia or sodium bicarbonate (baking
soda) and water. It is then heated to remove the hydrochloride, producing a form
of cocaine that can be smoked. This form of cocaine comes in a rock crystal that
can be heated and its vapors smoked. The term ‘crack’ comes from the crackling
sound made when it is heated” (Office of National Drug Control Policy, 2008).
The intensity and duration of crack cocaine’s effects, including increased
energy, reduced fatigue, and mental alertness is heightened the faster the drug is
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absorbed into the bloodstream and delivered to the brain. Inhaling crack cocaine
vapors produces a quicker, stronger high than snorting or smoking. For the crack
user, that’s good news and bad news: a stronger high results but the faster
absorption means a shorter high – the high from snorting cocaine may last 15 to
30 minutes but the high from smoking crack may last only five to 10 minutes. In
order to sustain the high, a crack cocaine user has to smoke the drug again,
which often results in binges or taking the drug repeatedly within a relatively short
period of time, at increasingly higher doses (National Institute on Drug Abuse,
2010).
By The Numbers
According to the 2008 National Survey on Drug Use and Health (NSDUH),
approximately 8.4 million Americans aged 12 or older (representing 3.4% of this
population) reported trying crack cocaine at least once during their lifetimes.
Additional 2008 NSDUH data indicated that approximately 1.1 million Americans
aged 12 or older (0.4% of this population) reported past year crack cocaine use
and 359,000 of Americans aged 12 or older (0.1% of this population) reported
crack cocaine use within the past month of when the survey was conducted
(Office of National Drug Control Policy, 2008).
The NSDUH estimated that in 2007 there were 2.1 million current (pastmonth) cocaine users. Adults aged 18 to 25 years have a higher rate of current
cocaine use than any other age group, with 1.7% of young adults reporting pastmonth cocaine use. Overall, men report higher rates of current cocaine use than
women. Ethnic and racial differences also occur with the highest rates in those

5
reporting two or more races (1.1%), followed by Hispanics (1.0 %), Whites (0.9
%), and African-Americans (0.8 %) (National Institute on Drug Abuse, 2010).
The 2008 Monitoring the Future survey, which annually surveys teen
attitudes and drug use, reports that while there has been a significant decline in
the 30-day prevalence of powder cocaine use among 8th-, 10th-, and 12thgraders from its peak use in the late 1990s, there was no significant change in
current cocaine use from 2001 to 2008; however, crack use declined significantly
during this timeframe among 8th- and 12th-graders (National Institute on Drug
Abuse, 2010).
In 2007, according to the NSDUH, nearly 1.6 million Americans met
Diagnostic and Statistical Manual of Mental Disorders criteria for dependence or
abuse of cocaine (in any form) in the past 12 months. Data from the 2005 Drug
Abuse Warning Network (DAWN) report showed that cocaine was involved in
448,481 of the total 1,449,154 visits to emergency departments for drug misuse
or abuse. Therefore, almost one in three drug misuse or abuse emergency
department visits (31%) involved cocaine (Office of National Drug Control Policy,
2008).
According to the Office of National Drug Control Policy (2010), during
2004 cocaine was the primary drug involved in federal drug arrests. “There were
12,166 federal drug arrests for cocaine in 2004. The Drug Enforcement Agency
made 7,082 arrests for powder cocaine and 3,921 arrests for crack cocaine
during 2004. During FY 2008, there were 6,168 federal defendants sentenced for
crack cocaine-related charges in U.S. courts. Approximately 95.9% of these
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cases involved crack cocaine trafficking. Approximately 0.5% of the crack
cocaine cases involved simple possession (Office of National Drug Control
Policy, 2008).
An article in the March 3, 2008, issue of Newsweek discussed the impact
of governmental programs such as the War on Drugs initiated by President
Richard Nixon in 1971 and the creation of the Drug Enforcement Administration
in 1973 on the criminalization of drug use. “Between 2000 and 2006, the number
of drug offenders in federal prison jumped 26%, to 93,751. An additional 250,000
are incarcerated in state facilities and thousands more sit in local jail cells. This
year the government has budgeted close to $13 billion for drug control, treatment
and prevention” (Kalb, Newsweek, 2008, p. 41). That $13 billion budget was
broken down with $8.3 billion going toward stopping drug flow into the United
States and enforcement of drug laws and $4.6 billion devoted to treatment and
prevention programs (Kalb, 2008).
Physical Ramifications
Crack cocaine is typically smoked through a simple glass pipe. The drug
reaches the brain within seconds, with the amount of crack controlled by the
depth of the smoke inhalation and frequency of the puffing. The effect of the drug
is an extremely euphoric feeling – an intense pleasurable sensation from the high
or rush. The state of euphoria intensifies normal pleasures, “a release of social
inhibitions, talkativeness, and an unrealistic feeling of cleverness, great
competence, and power” (Goldstein, 1994, p. 182). With sexual feelings
heightened, crack users may engage in risky behavior such as unprotected sex
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or sex in exchange for the drug, resulting in increased exposure to sexually
transmitted diseases, including AIDS (Goldstein, 1994).
With crack cocaine, a rapid tolerance develops even before drug
concentration in the blood dissipates. Binge use may result as the user tries to
keep the high going. Binges may lead to psychotic behavior, including extreme
paranoia, visual and auditory hallucinations and sensory sensations such as
bugs crawling under the skin. A binge typically lasts 24-hours or longer, followed
by a state of depression when the drug supply is depleted. Without the drug,
cravings for the drug become so intense that seeking the drug becomes all
important, to the detriment of everything else – family, job, food, hygiene, sleep
and rational behavior (Goldstein, 1994).
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CHAPTER 2
THE BRAIN’S ROLE IN ADDICTION
Humans are hard wired to seek natural reinforcement from food, water,
sex, and social interaction for survival and propagation of the species. The
changes that take place within the brain, specifically the mesocorticolimbic
dopamine system, are the focus of ongoing research into the critical role this
system plays in supplying positive reinforcement from drugs. By understanding
how the brain functions when crack cocaine is used/abused provides an integral
piece of the addiction puzzle.
Anatomy of the Addicted Brain
The mesolimbic dopamine system in the brain is comprised of the ventral
tegmental area, the basal forebrain, which consists of the nucleus accumbens,
olfactory tuberal, amygdala, and frontal and limbic cortices, and the dopaminergic
connection between the ventral tegmental area and the basal forebrain (Koob,
2006). This system, also called the reward system, “mediates biologic appetites
such as hunger, thirst and sexual drive” (Floyd & Seale, 2002, p.31). These
appetites are “located at a rudimentary level in the brain. They are operating in
neuronal systems well below the cerebral cortex and conscious thought” (Floyd &
Seale, 2002, p. 31). Neurons of this system “with cell bodies in the ventral
tegmental area and synapses in the nucleus accumbens, are primarily
dopaminergic” (Floyd & Seale, 2002, p.31).
The process of communication between brain cells is explained by
Shuman, National Institute on Drug Abuse (NIDA Notes, 2007):
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“The task in neurotransmission is to convey a signal from a
sending cell to a receiving cell across an open space known as a
synapse. All brain cells accomplish this in approximately the same
way.
The sending cell manufactures neurotransmitter molecules
and stores them in packets called vesicles. When stimulated
appropriately, the cell generates an electric signal and causes
some vesicles to migrate to the cell membrane, merge with it, open
up, and release their contents into the synapse. Some molecules
drift across the synapse and link up, lock-and-key fashion, with
molecules called receptors on the surface of the receiving cell.
Receptors bridge the receiving cell’s membrane; they have one
facet on the outside and one on the inside of the cell. When the
neurotransmitter links up with the exterior facet, the interior facet
precipitates an electrical response in the cell membrane or inside
the cell. The result may be increased production of some cell
product or—often—a repeat of the process just described, so that
the message gets relayed in turn to the next cell in the circuit.
At this point, cell-to-cell communication is complete. The
neurotransmitter molecules drop off the receptors. Loose again in
the synapse, they meet three fates:


Some attach to another receptor;
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Some encounter an enzyme, a chemical that breaks
them apart; and



Some reenter the sending cell via a special pathway
through the axon membrane, called a transporter.

Once back inside the cell, they are available for re-release in
future neurotransmission episodes.
Normally, when drugs are not present, the cycle of release,
breakup, and cell re-entry maintains the amount of neurotransmitter
in the synapse, and hence neurotransmission, within certain limits.
In most cases, when an abused drug enters the brain, it causes
neurotransmission to increase or decrease dramatically beyond
these limits” (NIDA Notes, 2007).
An important finding regarding dopamine, a neurotransmitter located in the
nucleus accumbens, was established by Nader through research he and his
associates conducted with rhesus monkeys at Wake Forest University. Nader
found that “cocaine lowers availability of the dopamine D2 receptors in the basal
ganglia—the brain region that includes key components of the reward system.
The consequences may include addiction-promoting alterations in cognitive
functioning and decision making” (NIDA, 2009).
The study confirmed that animals with lower D2 receptor availability were
especially responsive to cocaine's reinforcing effects. An explanation of a D2
receptor was provided by Childress: “Cocaine-addicted adults with long histories
of addiction had low numbers of dopamine (type ‘D2’) receptors in the striatum (a
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critical way station in the reward circuitry), as compared with controls who had no
history of any substance abuse (Childress, 2006, p. 51). This finding is important
for people trying to recover from cocaine addiction because receptor availability
levels in some of the monkeys used in Nader’s research recovered after less
than one year after being removed from cocaine administration. Nader
“measured the monkeys’ D2 receptor availability before cocaine exposure by
injecting each animal with a radiotracer that bound to the receptors. The
radiotracer competed with dopamine for the receptor and provided a measure of
D2 function. Over the course of a three-hour brain imaging study, the scientists
used positron emission tomography (PET) to visualize and quantify the bound
radiotracer” (NIDA, 2009).
The monkeys were allowed to self-administer cocaine in an “experimental
chamber equipped with two levers—one that delivered banana pellets during the
first 20 minutes of the test and another that provided the animal with an infusion
of cocaine during the next 60 minutes. Then, the researchers put the animals
through this sequence a second time. To describe the neurobiological effects of
chronic cocaine exposure, the investigators continued the self-administration
experiments and measured D2 receptor availability for a year” (NIDA, 2009).
The monkeys whose PET scans revealed lower D2 receptor availability at
baseline testing before their initial cocaine exposure, self-administered cocaine at
higher rates. “This finding suggests that lower D2 receptor availability increases
sensitivity to cocaine reward” (NIDA, 2009). PET scans administered after five
days of self-administration of cocaine showed that the monkeys’ available
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receptors had dropped by 15%, on average. What was significant was that three
monkeys that were allowed to self-administer the drug for only one week, D2
receptor availability returned to baseline values by the third week of abstinence
(NIDA, 2009).
Of particular importance was the inability of two of the monkeys in Nader’s
study to recover D2 receptor availability following year-long cocaine selfadministration. While these monkeys were self-administrating cocaine, they
exhibited a reduced attraction to food. While the monkeys were able to press a
lever for food, they did so only half as often as the monkeys whose receptors
returned to baseline after long-term cocaine self-administration. According to
Nader, “Although the findings are preliminary, we believe that these individuals
may find rewards other than cocaine devalued. If it is not cocaine, it is just not
rewarding to them” (NIDA, 2009).
Childress (2006) agreed that low D2 dopamine receptors influence
vulnerability to addiction. Brain-imaging showed that cocaine-addicted adults,
who reported long-term cocaine abuse, actually had low numbers of type D2
receptors. Childress noted that the finding goes against what was expected –
that addicted individuals would have more dopamine receptors and would
experience a greater (positive) drug effect and might become more easily
addicted. Other research cited by Childress found that people in the control
group (no addictions), who responded positively to an “infusion of the stimulant
methlphenidate” (Childress, 2006, p. 51), had D2 receptors that were at levels as
low as cocaine addicts who had abused cocaine for many years. The same study
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found that individuals with normal levels of D2 receptors found the stimulant too
powerful and unpleasant. This finding suggests that a higher D2 receptor level
may actually protect an individual from becoming drug dependent (Childress,
2006).
The firing of dopamine cells by the introduction of drug conditioned
cues was studied by Goldstein, Tomasi, Alia-Klein, Carrillo, Maloney, Woicik,
Want, Telang and Volkow (2009). By introducing drug-related and neutral words
to cocaine-addicted individuals and controls, researchers hypothesized that the
drug-related words would trigger activation in the mesencephalon, the area of the
brain where dopaminergic cells are found in the cocaine addicted subjects. Using
functional magnetic resonance imaging or fMRI, researchers demonstrated that
drug-related words activated the mesencephalon in the cocaine addicted
individuals.
Fifteen individuals with cocaine use disorders and 15 control
participants, matched on sex, age, education, and general intellectual
functioning, completed screening and gave written informed consent to
participate. Participants were scanned during a drug word fMRI task while
viewing drug or neutral words.
Using repeated measures ANOVA with verbal fluency showed
group by word interaction (p<0.01). Post hoc t tests showed that the interaction
was explained by higher drug than neutral responses in the cocaine users
(p<0.05) but not in healthy participants, where a trend toward the reverse pattern
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was shown and a significant difference was shown between the study groups for
the drug words only (drug: p<0.05; neutral: p>0.3) (Goldstein et al. 2009).
For the first time, it was shown that drug words defined as “uniquely
human learned verbal descriptors of stimuli” (Goldstein et al., 2009, p. 6004),
increased fMRI responses in the mesencephalon, “a major source of
dopaminergic release to motivationally salient or conditioned stimuli in cocaine
addicted individuals” (Goldstein et al., 2009, p. 6004). According to the authors,
“Our results for the first time demonstrate that, in addicted individuals, drug
words alone can elicit an fMRI-BOLD (blood oxygenation level dependent)
mesencephalic response, as possibly associated with
dopaminergic…mechanisms…that are crucial to conditioning” (Goldstein et al.,
2009, p. 6005). The authors concluded that the ease of administration of the brief
verbal fluency test and fMRI cue reactivity “could be used as a biomarker of
neurobiological changes in drug addiction” (Goldstein et al. 2009, p.6005).
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CHAPTER 3
BEHAVIOR ANALYSIS: TOOLS FOR CHANGE

As important as brain research is to addiction, without the associated
behavior – learning to use the drug, seeking the drug, buying the drug,
administering the drug, avoiding discovery – the research would be moot. In
other words, the brain does not operate alone. Without learning addictive
behaviors, individuals would receive a high from the brain’s naturally occurring
release of neurotransmitters, such as dopamine, after a satisfying meal, looking
at a beautiful work of art or after a sexual experience.
An individual does not inherently know how to “do drugs.” He or she must
learn the nuances of using drugs. White (1996) described a “culture of addiction”
that meets the needs of its members that are unmet by society-at-large:
“The culture of addiction is a way of life, a means of
organizing one’s daily existence, and a way of viewing people and
events in the outside world. It is a way of talking, walking dressing,
gesturing, believing, mating, working/playing, thinking, and seeing
that separates people who are ‘in the life’ from those who are not.
The culture of addiction encompasses values, artifacts, places,
rituals, relationships, symbols, music and art, all of which reinforce
one’s involvement in excessive drug consumption.
The culture of addiction can play a role in both initiating and
sustaining substance abuse disorders” (White, 1996, p. 5).

16

The tools of behavior analysis provide insight into the “why” of addictive
behavior, as well as approaches that give individuals living a drug dependent
lifestyle the options to return to a life free of life-altering substances. A key to
unlocking the “why” of addiction is functional analysis.
According to Jakes (2001), the origin of functional analysis goes back to
operant conditioning, and he attributed B.F. Skinner, who used individual
subjects to look at the “relationship between stimulus and response” (Jakes,
2001, p. 133) as a psychologist who believed functional analysis “explained how
the occurrence of certain behaviors was a function of specific stimuli”(Jakes,
2001, p.133). Jakes explained that the “key aim of a functional analysis was to
establish the situations in which symptoms or problem behaviors occur, and the
apparent consequences of these behaviors” (Jakes, 2001, p. 133).
Jakes (2001) pointed to Wolpe for making functional analysis a clinical tool
for psychologists and others. It was Wolpe who made the connection between a
behavior and the individual’s learning history. Using anxiety as an example,
Wolpe hypothesized that if you understood the learning history of a symptom,
you would understand the cause of the symptom and thereby help the individual
by helping he or she unlearn the association (Jakes 2001).
The National Institute on Drug Abuse website concerning drug treatment,
noted that every time an individual used cocaine during treatment, the therapist
and patient should do a functional analysis – “identifying the patient’s thoughts,
feelings, and circumstances before and after the cocaine use.” The NIDA states
that “early in treatment, the functional analysis plays a critical role in helping the
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patient and therapist assess the determinants, or high-risk situations, that are
likely to lead to cocaine use and provides insights into some of the reasons the
individual may be using cocaine (e.g., to cope with interpersonal difficulties, to
experience risk or euphoria not otherwise available in the patient’s life)” (NIDA,
2010).
Medical professionals are likely to encounter patients who are exhibiting
symptoms of addiction. Bloom and Smith (2001) advocated a functional
assessment that included a description of the sequence of events before, during,
and after the problematic behavior, exploration of reinforcements – what needs
are not being met and what the patient finds pleasurable. In addition, clinicians
should try to discover what attempts have been made in the past to resolve the
behavior and to identify “noxious or extinguishing responses” (Bloom & Smith,
2001, p. 109).
In a medical setting outside of the office, the medical professional may
offer referral to crisis counseling, addiction treatment or other services following a
medical emergency such as an attempted suicide, rape, battery or other crisis.
Individuals in a state of medical crisis will respond to the health professional’s
suggestion for follow-up care with a reliable community resource, if there is a
caring, non-judgmental interaction during the course of treatment (Hoff, 2001).
One of the problems with functional assessments for crack addicted
individuals is the inability for direct observation of the undesirable behavior. It
would be unethical as well as illegal to advocate use of an illicit substance for the
purpose of observing the events that precede use, the actual using behavior and
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the resulting aftermath. Functional analysis for crack using individuals must rely
on indirect functional behavior assessments.
While family members and others may contribute valuable information
regarding an individual’s drug use, the primary source of information is most
often obtained from the individual during the admission process to inpatient and
outpatient treatment programs. During the interview process for admission to a
rehabilitation program, individuals may be under the influence of a substance or
substances, under duress from parents, spouses or police, or may be in denial
regarding the degree of their dependence on a substance or substances. At the
time of the initial interaction, the individual may be facing a crisis situation
including overdose or suicide ideation, loss of residence, loss of employment,
loss of one or more relationships, medical emergencies or a legal crisis (Ramsay
& Newman, 2000). Any or all of these factors may result in unreliable information
that may be subsequently used as the basis for admission or denial for
admission to a treatment program.
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CHAPTER 4
UNDERSTANDING POSITIVE REINFORCEMENT/NEGATIVE
REINFORCEMENT IN ADDICTION

In behavior analysis terms, positive reinforcement occurs when a behavior
is “followed immediately by the presentation of a stimulus that increases the
future frequency of the behavior in similar conditions,” whereas a negative
reinforcement is a stimulus “whose termination or reduction in intensity functions
as reinforcement” (Cooper, Heron & Howard, 2007, pp. 700-701).
With addiction, positive reinforcement may be viewed as euphoria from a
normal state experienced by the user after self-administration of a drug, which is
quickly followed by negative reinforcement – the need to take more of the drug to
relieve the effects of withdrawal and the loss of the euphoric state. Both positive
and negative reinforcement are believed to be contributing factors to the
addictive properties of drugs. Wise (1988) proposed that positive and negative
reinforcers could be scientifically distinguished by the various parts of the brain
they activate.
A psychomotor stimulant theory of addiction, according to Wise (1988),
grew out of research on biological mechanisms of drive and reinforcement. “It is
an extension of the view that positive reinforcers are stimuli that elicit a variety of
species-typical, biologically primitive reactions, including eating, drinking,
copulation, nest building, etc.”(Wise, 1988, p.119). These types of positive
reinforcers are called forward locomotion, which Wise reported was first studied
by Schneirla in 1959 and correlated with brain stimulation reinforcement by
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Glickman and Schiff in 1967. Wise proposed an empirical study to determine if
positive and negative reinforcers could be separated by the areas in the brain
they activate (Wise 1988).
The summarization of numerous research studies on brain stimulation
reinforcement, amphetamine and cocaine reinforcement, opiate reinforcement,
food and water reinforcement, the “motor” – “psychomotor” distinction, and brain
mechanisms of negative reinforcement by Wise (1988) provide insight into
complex theories regarding brain function and the relationship to addiction. Of
particular interest is the section Wise (1988) devoted to the implications of these
research studies, some of which follow:


The importance of distinguishing between cravings that result from a
history of positive reinforcement or from a present condition of negative
reinforcing potential of the drug. Remembering past positive
reinforcement is key in initial addiction and relapse after long periods of
detoxification.



Opiates and cocaine activate the same neural circuitry and either will
cause a return to drug dependence in ex-addicts. Nicotine may be an
underestimated stimulant to cause relapse.



Pharmacological approaches to addiction are ineffective if only used to
treat withdrawal symptoms of detoxification. Any dopamine agonist
should relieve cocaine craving by targeting the same target neurons in
the same positive reinforcement pathway as cocaine (Wise 1988).
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The conclusion that Wise reached is concerning. Wise postulated that if
the positive reinforcing properties of addictive drugs occur within the physical
structure of the brain, their reinforcement may be more powerful than naturally
occurring environmental stimuli such as “nature, art, or music. Whereas the
signals from natural reinforcers depend on sensory transducers and the
propagation of nerve impulses across axons and synaptic junctions, drugs can
activate reinforcement mechanisms centrally, saturating receptor mechanisms
that may never be saturated as a consequence of natural reinforcement” (Wise,
1988, p. 127).
An effect called priming is closely associated with the reinforcing
properties of addictive drugs. Even after long periods of abstinence, taking even
a small amount of their drug of choice, can lead to a full-blown relapse. This
priming effect was the impetus for a study by De Wit and Stewart in the mid-80s,
which was described by De Wit (1996). After rats were trained to deliver daily
self-administered cocaine or heroin, they were put on periods of extinction. After
one or two hours on extinction, rats exhibited no drug seeking behavior. A
researcher then administered an injection of the self-administered drug, a
different drug or saline. The rats given injections of cocaine, which was the selfadministered drug, returned to drug seeking behavior for cocaine as was the
case with rats that self-administered heroin and were given heroin after
extinction. Heroin given to the cocaine addicted rats did not serve as a priming
effect nor did cocaine given to the heroin addicted rats, which demonstrated drug
specificity (de Wit 1996).
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Conversely, human subjects are many times long-time drug abusers
whose prior drug using history may affect responses through physiological
consequences of a drug and/or conditioned or learned effects. In addition, the
dependent measures with human subjects are frequently self-reports of drug
craving and use whereas the dependent variables with laboratory animals are
observed drug seeking and using behaviors (de Wit 1996).
De Wit (1996) cited numerous research hypotheses for the priming effect
including classical conditioning, incentive motivation and operant conditioning, all
of which needed more empirical study. De Wit (1996) discussed an interesting
theory by Marlatt that a one-time lapse of a previously abused drug leads to
increased and ongoing use of the drug due to a sense of failure on the part of the
addict. De Wit (1996) stated that while this theory is “plausible,” it applies only to
drug users who are trying to quit their drug use and not to those who are not
attempting to quit such as social drinkers. Further “systematic parametric” studies
that investigate “the time course, stability, dose-dependence, contextdependence and specificity” of the priming effect are necessary, according to De
Wit, in order to “discover the underlying behavior mechanisms” (de Witt, 1996,
p.9) of the phenomenon.
Delayed Discounting in Addiction
Drug dependence has been shown to cause a phenomenon known as
delayed discounting – a “foreshortening of time perspective, so that longer term
delayed rewards are discounted in value” (Miller & Carroll, 2006, p.298). Delayed
discounting is defined as a “behavioral process that values delayed reinforcers
less than reinforcers that are not delayed” (Bickel & Potenza, 2006, p. 11). The

23
extent of discounting may be measured by psychosocial procedures where an
individual chooses between an immediate reinforcer or reward and a delayed
reinforcer. Bickel and Potenza (2006) provide the following example of delayed
discounting: “What could provide more specific knowledge regarding the extent
of discounting is identifying the amount of immediately available money that the
chooser values approximately the same as delayed money. This information can
be obtained by progressively decreasing the amount of the immediately available
money across trials (e.g., $975, $950, $925) and keeping the delayed amount
unchanged ($1,000), and then identifying the specific monetary amount that
results in the chooser’s switch from the immediate to the delayed amount” (Bickel
& Potenza, 2006, p. 11). The authors added, “A substantial body of literature
suggests that drug-dependent individuals (alcohol-, cocaine-, heroin-, tobaccodependent) discount money substantially more than matched control normals
and that the drug dependent substantially discount their drug of dependence
more than an equivalent amount of money” (Bickel & Potenza, 2006, p.12).
Contingency Management Models
As discussed previously, finding rewards to replace the powerfully
addictive properties of crack cocaine and other drugs may seem impossible to
achieve. One tool that is supported in the addiction literature is the use of
contingencies in achieving abstinence and other target behaviors such as
treatment attendance. While contingency management models are not without
problems, such as a return to substance use upon termination of the use of a
contingency, the use of contingencies to retain individuals in treatment and
maintain abstinence results in more positive outcomes in personal areas such as
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employment, interpersonal relationships and medical issues and psychological
functioning show promise(Carroll & Rounsaville, 2006).
The effect of an alternative reinforcer, such as varying amounts of money
on the self-administration of smoked cocaine, was a secondary purpose of a
study undertaken by Hatsukami, Thompson, Pentel, Flygard, and Carroll (1994).
According to the authors, the primary purpose was to address methodological
issues associated with using smoked cocaine in a parametric design. Study
participants, 12 male cocaine abusers, ages 24-41, completed extensive
medical, legal and psychiatric histories, as well as their histories of drug use.
Medical examinations, including electrocardiogram, pulmonary function test,
chest x-ray, urine analysis, and blood chemistry panel were performed on all
participants. Inclusionary criteria was extensive and required only cocaine and
nicotine use, history of smoked cocaine use at least twice weekly for the six
months preceding the study, no psychiatric disorders, no major medical
problems, a negative test for HIV, no history of violence and a last chemical
dependence treatment at least 12 months previously (Hatsukami et al., 1994) .
Subjects stayed for eight days (not concurrently) in an inpatient unit of a
clinical research center where they were closely monitored by medical personnel
during the course of the study. Following two pre-experimental days when no
cocaine was administered, subjects were familiarized with equipment and
procedures. On the first day of the study, subjects attended four experimental
sessions. For the first three sessions, they received one of three possible doses
of cocaine – 5.0 mg, 0.2 mg/kg, or 0.4mg/kg, with “the 5.0 mg considered to be a
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low dose with minimal subjective and physiological effects” (Hatsukami et al.,
1994, p. 117). Order of the doses was randomized and subjects received only
one dose per day. During the fourth session, one of the doses was repeated and
was randomly selected. (Hatsukami et al., 1994).
An IV catheter was placed in the non-dominant arm of the participant for
blood monitoring and for IV access in case of emergency. For one hour, baseline
measurements were recorded, followed by a sample dose of that day’s dose
size. Participants were given 10 tokens, each worth a specified amount of
money, and told that they could use the tokens on up to 10 deliveries of a similar
dose size of cocaine or turn them in for the specified amount of money ($2, $3,
$5 or $7). The monetary value varied across subjects but not within subjects.
After 30 minutes, a green light indicated participants could purchase another
dose of cocaine with a token. Thirty minutes were taken between cocaine
deliveries. Blood pressure, heart rate and ECGs were recorded at varying
intervals. Subjects were required to remain seated in the room with the
procedure repeated until either 10 doses were taken or five and one-half hours
had elapsed. If no cocaine was administered, readings were not taken of blood
pressure, etc., until the next cocaine delivery. Unused tokens were turned in for
money. Tokens could not be used to buy cocaine during other sessions. Money
was not given out until the end of the study. Following the delivery of cocaine,
two post-experimental days followed and the same measures were taken as
during the pre-experimental phase (Hatsukami et al., 1994).
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The study found that higher doses of cocaine were selected over lower
doses. Data analysis showed that “if the magnitude of the alternative reinforcer or
the cost of cocaine was smaller, subjects were more willing to self-administer
cocaine than if the magnitude of the alternative reinforcer or the cost of cocaine
was higher” (Hatsukami et al., 1994, p. 123). The authors acknowledged that the
small number of participants and the varying costs of cocaine and the total
amount of money available may “temper” the study’s findings (Hatsukami et al.,
1994).
Katz, Chutuape, Jones, and Sitzer (2002), used an abstinence-contingent
voucher with heroin addicts who also abused cocaine. Fifty-two opiatedependent subjects who recently completed an inpatient detoxification program
and were enrolled in an outpatient treatment program within seven days of
inpatient discharge participated in the study. Following consent, subjects
provided a urine sample, completed an assessment battery and were introduced
to their counselors. Subjects were grouped by urine sample results, detoxification
program of referral, and living arrangements and were then randomly assigned to
either treatment with or treatment without voucher incentives. Twenty-nine
participants were assigned to the voucher condition; 23 subjects were assigned
to the no-voucher condition. Both groups were asked to attend the clinic three
times per week for three months, to submit urine samples under observation and
participate in cognitive-behavioral counseling. Subjects were not mandated to
attend either the research component or the counseling sessions (Katz et al.,
2002). During the next three months of the study, counseling was offered once
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each week and two group sessions, a Job and a Social Club, were available. The
Job Club focused on employment skills such as interviewing. Clients participated
until they became employed. During the Social Club, participants ate lunch and
interacted with non-drug using peers so long as they were abstinent. Clients
were provided with bus tokens or parking passes for each counseling session
they attended. Missing seven consecutive counseling sessions resulted in
dismissal from the study. Counselors were allowed to give $20 attendance
vouchers to subjects who had missed up to three sessions as an incentive to
return to counseling. Attendance incentives were given by mail 51 times during
the study to 40 subjects – 79% were voucher clients and 74% were no-voucher
clients. Letters were followed by counseling attendance on 23.5% occasions
(Katz et al., 2002).
Vouchers were earned for each urine sample provided that was negative
for both opiates (heroin) and cocaine. Vouchers were worth a designated
monetary amount and could be exchanged for goods and services. Subjects
earned $2.50 for the first opiate- and cocaine-negative urine samples, with the
value increasing by $1.25 for each successive negative urine sample. For each
set of three consecutive negative urine samples, clients earned a $10 bonus.
Missing an appointment or submitting a positive urine sample, resulted in the
voucher value being reset to $2.50. If the value was reset and the next five
consecutive urine samples were negative, voucher values were reset to the
earnings level reached before the reset. To encourage early engagement with
the study, clients received a one-time $100 bonus for the first three consecutive
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opiate- and cocaine-negative urine samples. While the three consecutive
negative urine samples could be done at any time during the study, 73% of the
earned bonuses were collected during the first three months. For remaining drug
free throughout the study, a total of $1,087.50 could be earned (Katz et al.,
2002).
Days in treatment, total number of research visits, total number of
counseling sessions, number of negative urine samples, longest duration of
continuous abstinence and percentage of clients with one, two and four weeks of
continuous abstinence were the measures used to compare outcomes for
voucher and no-voucher subjects. Clients in the voucher condition earned an
average of $171 in vouchers; four clients earned no vouchers, 10 earned less
than $10 in vouchers and 15 clients earned more than $10 in vouchers. Because
clients were not mandated to attend research visits or counseling sessions,
retention was calculated as the day of initial intake to day of the last face-to-face
contact, either research or counseling visit. Mean days in treatment for voucher
subjects was 35.9 out of a possible 180; 39.3 days for no-voucher subjects.
Clients in the voucher group submitted, on average, 8.3 opiate- and cocainenegative urine samples versus 6.2 opiate- and cocaine-free samples from the novoucher group, out of a total possible of 36 samples over the course of the study.
Groups differed “significantly on intake urine results at study onset: those
negative at intake made more research visits (M=11.5), submitted significantly
more negative urine samples (M=9.9) and had significantly longer durations of
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continuous abstinence (M=19.8). There was no significant interaction between
intake urine status and voucher incentive condition” (Katz et al., 2002, p. 140).
Overall results found that a voucher incentive program did not improve
retention or drug abstinence outcomes for recently detoxified heroin addicts who
were required to abstain from both heroin and cocaine use to earn vouchers
during outpatient treatment. Two voucher incentive programs cited by the
authors, specifically Downey et al. (2000) and Piotrowski et al. (1999), concluded
that there was one constant in both studies, which was “some patients never
contact the reinforcer because they never submit a drug-negative urine. This was
true for 50% to 50% of clients in the two studies described above but was less of
a factor in the present study, where 86% of clients submitted at least one
negative urine sample” (Katz et al., 2002, p. 141).
The Katz study (Katz et al., 2002), which used subjects with dual-drug
addictions discussed two possible improvements for future research – allowing
participants who use more than one drug to stop using one drug at a time and to
increase the value of the reinforcer to establish greater levels of compliance. The
authors also cited possible reasons for their study results which included lapse
and relapse function in heroin versus cocaine users. Recently detoxified heroin
users may have a harder time in the early stages of abstinence due to the
severity of withdrawal symptoms compared with participants who experience
cocaine withdrawal. Another possibility was that the counseling provided in the
study might have been more effective had it included “outreach efforts designed
to retain clients in treatment by contacting them in the community when they fail
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to show up for appointments” (Katz et al., 2002, p. 141). Providing stronger
attendance incentives and allowing for a more flexible attendance schedule for
an opiate addicted population may have resulted in stronger outcomes (Katz et
al., 2002).
One study (Petry, Alessi, Carroll, Hanson, MacKinon, & Rounsaville,
2006) used two approaches of prize-based contingency management with 131
substance abusing outpatients at a community clinic randomly assigned to one of
three 12-week treatments: standard treatment, standard treatment with
contingency management for negative urine samples or standard treatment with
contingency management for completing goal-related activities. A heterogeneous
patient group consisting of heroin- and cocaine-abusing individuals was used to
increase the generality of study findings. Following informed consent and
inclusion criteria (“initiating a treatment episode at the clinic and met past-year
Diagnostic and Statistical Manual of Mental Disorders (4th ed.; American
Psychiatric Association, 1994) criteria for cocaine or heroin abuse or dependence
or evidenced recent use” (Petry et al., 2006, p. 593), a two-hour interview was
conducted to obtain demographic data, as well as diagnostic status. The
Addiction Severity Index (ASI) was administered to determine psychosocial
issues and breath and urine samples were collected to determine alcohol use,
which would exclude participants from the study. The ASI was repeated at one,
three (post-treatment), six and nine months after initiation of treatment. Subjects
received $15 for the one-month evaluation and $30 for the other evaluations.
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Follow-up rates exceeded 70% in each condition at each interval (Petry et al.,
2006).
Using a computerized randomization, groups were assigned to balance
age, gender, ethnicity, whether or not subjects received inpatient treatment prior
to seeking outpatient treatment, and whether subjects were unemployed,
employed full time or employed part time. Those assigned to the standard
intensive outpatient treatment condition participated in group sessions led by
various clinicians that covered relapse prevention, coping and life skills, 12-step
treatment and AIDS education for up to four hours each day over five days each
week for four weeks with gradual reduction in sessions. Breath and urine
samples were collected three days per week for the first three weeks and two
days per week during weeks four through six. In addition, to control for
“individualized attention associated with activity selection in one CM condition, a
research assistant met with subjects for 15 minutes every week to present
educational materials on health, alcohol, drugs, AIDS, stress management,
depression, the law, insomnia, hepatitis, smoking, family, drinking and driving,
and wellness” (Petry et al., 2006, p. 594).
With the exception of the individual education sessions, subjects assigned
to the contingency group that could earn prizes by completing goal-related
activities received the same treatment, including the collection of breath and
urine samples, as the subjects assigned to the standard treatment only condition.
Participants completed a needs assessment during the first week of the study
that evaluated problems in 10 areas: employment, education, family, housing,
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medical-psychiatric, legal, sobriety, social-recreational, personal improvement,
and transportation. Subjects selected two to four goals based on their
assessments and every week selected three activities to be completed the next
week in order to meet their long-term goals. Activities were not mandated but all
participants were encouraged to work on social-recreational and sobriety goals
(Petry et al., 2006).
When activities were completed and verified by receipts, brochures or
other documentation, one draw from a prize bowl was awarded for each
completed activity. Draws increased by one for every consecutive week that
three activities were completed. Five bonus draws were also awarded for every
week that three activities were completed for a total of 294 draws across the
study’s timeframe. If a participant failed to complete a selected activity, their draw
was reset to one draw per activity. When all three activities were done, earned
draws were reset back to the highest number attained prior to the failed
completion. The prize bowl contained 500 cards with 275 showing “Good job, try
again” and did not earn a prize. Of the 255 prize cards, 199 were small prizes
such as $1 fast food vouchers or a bus token, whereas 25 cards were large
prizes such as movie passes, phone cards, etc., and one card was for the largest
prize worth $100 in merchandise such as a DVD player or five of the other large
prizes (Petry et al., 2006).
In the third condition, subjects received the standard treatment, the 15minute education component, breath and urine collections, and instead of
choosing an activity for the chance to win prizes, participants in this group could
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win prizes for every negative specimen for heroin, alcohol and cocaine they
submitted. Petry et al. (2006) noted that positive specimens were most often for
cocaine use, followed by heroin use and lastly alcohol use. The first submission
of negative specimens earned one draw from the prize bowl with the number of
draws increasing by one for every consecutive negative specimen. A five-draw
bonus was earned each week if all samples were negative. If a participant tested
positive for any one of the three substances (cocaine, heroin or alcohol) or
refused to submit a specimen or was a no show, the number of draws went back
to one. After two consecutive weeks of negative specimens, the number of draws
was reset to the number earned prior to the above conditions. A total of 291
draws could be earned for submitting negative specimens for all 21 drops across
the 12-week study (Petry et al., 2006).
Findings from the study showed that contingency management led to
some improvements, however, the contingency management activity condition
was less effective than the contingency management abstinence condition in
“retention and some drug abuse outcome measures.” This finding was not in
keeping with the results of a study conducted by Iguchi et al. (1977) that showed
“contingency management treatment that reinforced activity completion resulted
in greater reductions in drug use than a contingency management treatment that
reinforced abstinence directly” (Petry et al., 2006, p. 599). Several reasons were
cited by the authors for the difference in findings:
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Methadone patients abuse more drugs and therefore have more
positive specimens during treatment; however, 99% of subjects in this
study achieved at least one negative sample.



Reinforcer type and magnitude varied between the studies (prizes in
this study and vouchers in the Iguchi study).



Activities were more difficult in this study (e.g., creating a resume) and
may have resulted in overall lower rates of reinforcement.



In this study there were few differences between the two contingency
management conditions based on ASI scores, which may reflect the
individualized nature of the activity choices.



A more comprehensive assessment instrument that allowed for more
areas of functioning might be more effective.



Subjects with an alcohol only assessment were excluded from the
study; their inclusion may have changed outcomes.



Urine samples were collected infrequently, which may not represent
actual return to drug use.



Engagement in targeted behaviors may not correspond directly to drug
use behavior changes (Petry et al., 2006).

Strengths of the study as noted by the authors included study design
which “specifically examined the important issue of target of reinforcement.
Overall scheduled magnitudes of reinforcement were equated between the two
contingency management conditions, and amount of time and personal attention
received by the research assistant were similar in all three conditions. Multiple
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outcome measures were assessed, and all showed some degree of
concordance. Reasonable sample sizes were included, and adequate rates of
follow-up were achieved. The study was conducted in a community-based
treatment program, with treatment as usual provided to all patients as the
standard of care” (Petry, et al., 2006).
Another study (Schmitz, Lindsay, Stotts, Green & Moeller, 2010) reviewed
the effectiveness of Levodopa, a dopamine precursor, versus a placebo, and its
effectiveness when combined with contingency management conditions that
targeted these behaviors: attendance, medication compliance, and cocaine
abstinence. The initial protocol demonstrated the effectiveness of levodopa
treatments versus placebo that included abstinence-based contingency
management. The second arm of the study was run concurrently in 2008 and
examined levodopa treatment effects across different contingency management
conditions. One hundred one subjects dependent on cocaine and seeking
treatment met inclusion criteria to participate in a 12-week, randomized,
placebo-controlled trial of levodopa. Subjects provided medical histories and
received a physical examination as well as laboratory tests for liver and thyroid
function and a cardiac evaluation. Blood pressure, heart rate and weight were
obtained each week. The Structured Clinical Interview and the Addiction Severity
Index were administered prior to the study. In the CM (contingency
management)-URINE condition, subjects were given vouchers worth cash
amounts for urine drops that were negative for cocaine; in the CM-ATTEND
condition, vouchers were earned for attending clinics three times each week; in
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the CM-MEDICATION condition, vouchers were earned for evidence of pill taking
behavior through monitoring by Medication Event Monitoring Systems and tests
to determine the presence of riboflavin (Schmitz et al., 2010).
Previous research noted in this study supported the use of contingency
management in reinforcing medication compliance such as with retroviral
medications in HIV-positive methadone patients. This study examined six
different treatment conditions: levodopa/carbidopa (800/200 mg/d) or placebo
given in combination with one of three different behaviors noted earlier. In the
CM-ATTEND condition, cash-valued vouchers were earned for attending clinic
visits three times each week; in the CM-MEDICATION compliance condition,
vouchers were earned contingent upon evidence of pill taking obtained by the
number of electronic cap openings by Medication Event Monitoring Systems and
evidence of riboflavin, administered at 100mg strength in the levodopa capsule.
Vouchers were earned based on cocaine-negative urine results in the CMURINE condition. In addition to medication dosing on an escalating schedule until
the final week of the study when dosing was reduced, subjects attended brief
meetings conducted by nursing staff three days each week. A missed session
could be rescheduled on an off day without penalty. A one-hour session that was
led following a manual on cognitive-behavioral therapy was also required. A
research assistant followed targeted behaviors and distributed vouchers each
week. Voucher values started at $2.50, increasing by $1.25 for each consecutive
occurrence of a targeted behavior. A $10 bonus voucher could be earned for
evidence of three consecutive occurrences of a targeted behavior. Subjects were

37
given written documentation of earned vouchers and the coinciding dollar
amount. Vouchers could be exchanged for gift certificates or for cash at any time
during the trial. Total amount that could be earned was $997.50 over the 12week period (Schmitz et al., 2010).
At the study’s half-way point, 51% of participants were continuing in the
study and during the final week of the study, 35% remained with a higher
retention level found in the CM-ATTEND condition. The study did not support the
hypothesis that levodopa would enhance the effectiveness of contingency
management rewards. “The observed lack of Levodopa versus placebo
differences on CM effects for attendance and medication compliance outcomes
fails to support a general reward enhancement explanation. That Levodopa
enhanced responding only under the urine-based intervention suggests a more
nuanced synergy between Levodopa and CM” (Schmitz et al., 2010, p. 242).
The authors concluded, “While most CM interventions target abstinence
outcomes, this study provides evidence of improved outcomes when targeting
therapeutic goals of clinic attendance and medication compliance, consistent with
previous reviews of CM effectiveness (Griffith et al., 2000; Lussier et al., 2006)”
(Schmitz et al., 2010, p. 242). The study’s finding that higher voucher earnings
were obtained in the CM condition that reinforced attendance meant that
targeting this behavior gave participants more opportunities for contact with
contingencies. The authors suggested shaping as a tool that could be used by
successively increasing the task’s difficulty by beginning with CM reinforcement
for clinic attendance, building on this behavior by adding medication compliance
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as another targeted behavior and subsequently, the target behavior of
abstinence (Schmitz et al., 2010).
Study limitations noted by the authors were small sample size and a high
attrition rate and added, “…although significant CM effects were found, actual
rates of responding were less than robust, perhaps because of variations in the
administration of the CM” (Schmitz et al., 2010, p. 243). Despite its limitations,
authors concluded that the strengths of the study, specifically its design, allowed
“testing of the independent and interactive effects of the treatment factors,” and
that contingencies were “well-defined using objective measures of the target
behavior” (Schmitz et al., 2010, p. 243). The study’s examination of the
interaction of levodopa and abstinence-based contingency management could
support a new approach for reward-based interventions that may successfully
compete with the highly addictive reinforcing effects of cocaine (Schmitz
et al., 2010).
Results of a meta-analysis by Prendergast, Podus, Finney, Greenwell and
Roll (2006) support the effectiveness of varied contingencies used during
treatment for illicit drugs and other substances such as nicotine and alcohol.
When contingencies are removed, targeted behaviors diminish slowly with time,
yet individuals are able to benefit from treatment with contingencies. The authors
caution that while drug users who are early in their use or for those who are not
in full blown dependence, reinforcement for abstinence only, with fewer services
and limited staff requirements may be effective for this population but the “limited
data on effect sizes following CM suggest that continuing care is warranted”
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(Prendergast et al., 2006, p. 1556) when using CM only with more dependent
drug users. The authors acknowledge a large body of empirical studies exists
regarding contingency management used with different drugs of abuse, a “high
methodological quality of CM studies,” and the “relatively high mean effect size
provide strong support for CM as being among the more effective approaches to
promoting abstinence during and after the treatment of drug dependence
disorders” (Prendergast et al. 2006, p.1556). Recommended future research,
according to the authors, should include “examination of the relative
effectiveness of different types of CM, further investigation of moderators of the
impact of CM and comparison of the effects of CM and other treatment
approaches” (Prendergast et al., 2006, p. 1556).
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CHAPTER 5
STAGES OF READINESS AND MOTIVATION FOR CHANGE

In spite of the highly addictive properties of crack cocaine and other
substances, change is possible but many times individuals enter treatment with
ambivalence about changing their behaviors (Ramsey & Newman, 2000). In
order for change to happen, the individual has to be ready to change. Frequently
referenced in addiction literature is an empirical transtheoretical protocol
consisting of five stages that define readiness for change (Prochaska,
DiClemente & Norcross, 1992; Center for Substance Abuse Treatment, 1999;
Bloom & Smith, 2001; Floyd & Seale, 2002; Edwards, Marshall & Cook, 2003).
The five stages are not linear in construct but rather circular to account for
the recycling that may occur by an individual through the various stages. The
stages and the defining elements (Prochaska et al., 1992) are:
1. Precontemplation: No intent to change; little insight about
ramifications of substance use; if in treatment probably mandated
by judicial system or by a significant other such as a spouse;
procrastination common.
2. Contemplation: More aware of problems caused by substance use
and may consider actions to change but there is no commitment to
a process of change; passively look at pros and cons of use; giving
“lip service” to change.
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3. Preparation: may take some steps to stop using such as reducing
use or avoiding use at certain times; plan in place for change and
state intention to start in near term.
4. Action: Steps taken to achieve targeted goals; can show specific
actions taken to alter addictive behavior with tangible results; feel
hopeful and empowered but vulnerable to relapse at any point in
time.
5. Maintenance: engaged in lifestyle changes for more than six
months; working on relapse prevention plan and solidifying
treatment targeted goals.
Individuals may move in and out of each stage. For example, an individual
may move from the action phase into relapse and be precontemplative about
changing or moving from relapse into a preparation stage that would allow
removal of obstacles that precipitated relapse. By basing interventions on where
the individual is in the change cycle, the therapist connects with the individual,
avoiding antagonism and improving the likelihood of success (Floyd & Seale,
2002).
In the stages of change model, therapists strategize with the client, do not
take on an authoritarian role and avoid confrontation. An atmosphere of
cooperation is created with the goal of increasing “the intrinsic motivation,” and
“leaving them with the responsibility to effect their own change” (Edwards et al.,
2003, p. 316). Early in the process, clients are helped to explore ambivalence
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using client-centered counseling, including open-ended questions, reflective
listening, affirmation, and summarizing (Edwards et al., 2003).
Goldstein (1994) noted, that Prochaska’s model provides “ … a practical
framework in the treatment setting” (Goldstein, 1994, p. 315). Clients in the
precontemplation stage are able to change and those in the action stage may
fail. Goldstein stated that the stages of change model is “over-simplified and
artificial” and “despite its shortcomings, the ‘stages of change’ model is routinely
used by clinicians in the alcohol and addictions field…” (Goldstein, 1994, p. 315).
Giovazolias and Davis (2005) conducted a study following Prochaska’s
model regarding matching appropriate therapeutic intervention according to the
stage of readiness for change in addictive clients. A distinguishing characteristic
of this study is that it focused specifically on the perspectives of individuals with
drug and alcohol issues, examining a client’s view as to the most appropriate
intervention in relation to their stage of readiness. The authors hypothesized that
“clients in the early stages would consider non-action interventions to be
significantly more helpful, while clients in the later stages would find actionoriented interventions to be more beneficial for them” (Giovazolis & Davis, 2005,
p. 175).
Clients in the study had drug and/or alcohol problems and were recruited
from an outpatient clinic within the National Health Service. Each participant
received an information sheet, consent form, two questionnaires and a stamped
addressed return envelope in which they were to return their questionnaire, either
drug or alcohol, based on their perceived addiction issue.
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The first questionnaire classified clients into one of the five stages of
change based on their “…recent drinking or drug use, reported intention to
change, and recent quit-change attempts” (Giovazolis & Davis, 2005, p. 176).
The second questionnaire, created by Giovazolis and Davis, included
demographic characteristics and questions specific to their histories of previous
treatment. Eight questions dealt with the type of therapy they thought would be
most appropriate at present. Using a five-point Likert scale, clients were asked to
indicate their degree of agreement or disagreement and the degree of
helpfulness or usefulness of treatment. Four of the eight questions represented
an “action-oriented, high structure counseling style, and four represented a nonaction, low structure facilitative approach” (Giovazolias & Davis, 2005,
p. 176). On receipt, the anonymous questionnaires were numbered in the order
they were received and were transferred to an SPSS statistical package for
analysis (Giovazolias & Davis, 2005).
Ninety-five completed questionnaires were turned in for a response rate of
53%; 55 were male and 40 were female. The majority of respondents were
between 31 and 40 years of age (21.1%), 62.1% reported drugs as their primary
addiction problem and of those, 61% were males and 39% were females.
Allocation of participants to the five stages of change were as follows: 14.7% in
the precontemplative stage; 21.1% in the contemplation stage; 18.9% in the
preparation stage, 20% in the action stage and 25.3% in the maintenance stage.
Statistical analysis indicated significant differences in preferences, with those in
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the early stages “showing a strong inclination to the non-action oriented
interventions (p<.001)” (Giovazolias & Davis, 2005, p. 177).
Outcomes of the study cited by the authors as being of interest were the
finding that the majority, 64.2%, of respondents were in the later stages of
readiness to change, which the author stated was logical since recruitment took
place at Drug and Alcohol Services and participants should be in at least the
contemplation stage of change because they had made the commitment to
attempt treatment. By comparison, 14.6%, a relatively large percentage based on
the sample size, were in the precontemplation phase, which was in agreement
with findings from similar studies. The study’s finding that more men were in the
earlier stages of change, while females were in the later stages, led the authors
to speculate that “perhaps men are more reluctant than women to recognize,
accept and seek help for their addictive problems” (Giovazolias & Davis, 2005, p.
179). The other interesting outcome the authors noted was that participants in
the earlier stages, irrespective of gender, “significantly prefer non-action oriented
therapeutic interventions than action-oriented interventions (Giovazolias & Davis,
2005, p. 179).
According to the authors, of even greater interest was their finding that “no
difference exists between those who had seen a therapist and those who did not
have this experience, in terms of their preferred therapeutic interventions”
(Giovazolias & Davis, 2005, p. 180). Rather than expecting a “magical solution”
(Giovazolias & Davis, 2005, p. 180), those who had not experienced therapy
were realistic about what would actually be of help to them. The study found a
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higher correlation between stages and preferred therapeutic intervention for
participants with drug addiction, “indicating that this group has a stronger
tendency to prefer non-action interventions when they are in the ‘early’ stages,
and action-oriented interventions when they are in the later stages of change”
(Giovazolias & Davis, 2005, p. 180). The results of the study “indicate that there
is a strong match between the theoretical predictions and the clients’ views on
this issue. In other words, it seems that clients in the ‘early’ stages of change (i.e.
Precontemplation, Contemplation), irrespective of gender or whether they had
seen a therapist in the past, consider non-action oriented therapeutic
interventions to be more beneficial for them, whereas clients in the ‘later’ stages
of change (Preparation, Action, Maintenance) regard action-oriented
interventions to be more helpful” (Giovazolias & Davis, 2005, p. 181).
A therapeutic intervention that is useful in motivating clients through the
stages of change is the Motivational Interview (MI), developed by William Miller,
and referenced frequently in addiction literature (Peele & Brodsky, 1991;
Substance Abuse and Mental Health Services, 1999; Miller & Rose, 2009). The
technique “draws on strategies from client-centered counseling, cognitive
therapy, systems theory and the social psychology of persuasion” (Peele &
Brodsky, 1991, p.183). Related to the stages of change, motivational
interviewing, set in an atmosphere of nonconfrontation, using “open-ended
questions, reflective listening, affirmation and summarizing,” motivational
interviewing helps the client to view the discrepancy between their behavior and
their targeted goals. Motivational interviewing “develops and amplifies this
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discrepancy, ultimately allowing the patient to present the reasons for change
without feeling coerced” (Peele & Brodsky, 1991, p. 183).
Interestingly, Miller’s technique came from an unexpected finding after
Miller trained nine counselors in behavioral self-control training and accurate
empathy. Three supervisors observed the trained counselors using these
techniques, using a rank ordering as to the extent the counselors used
empathetic understanding during therapy. At six, 12 and 24 months posttreatment, counselor empathy accounted for statistically significant outcomes for
therapist style and not for the behavioral interventions being compared and later
research by others confirmed this finding (Miller & Rose, 2009).
“A guiding principle of MI was to have the client, rather than the
counselor, voice the arguments for change” (Miller & Rose, 2009, p. 528).
Motivational interviewing was incorporated into different models of treatment by
Miller and others. Three clinical trials (Miller and Brown, 1993) randomly
assigned participants in each trial into one of two groups: one MI session at the
onset of treatment or no MI session at the start of treatment. In all trials,
participants who received the MI session at outset of treatment showed “double
the rate of total abstinence three to six months after inpatient treatment” (Miller &
Rose, 2009, p. 528).
With more than 200 clinical trials published and efficacy reviews and
meta-analyses conducted, MI has found positive outcomes in trials conducted on
cardiovascular rehabilitation, diabetes management, problem gambling, and
others in addition to substance use. Multi-site trials have been conducted using a
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form of MI that combines MI with motivational enhancement therapy (MET). MET
is defined in a study conducted by Lawendowski (1998): “Motivational
Enhancement Therapy (MET) embeds MI within a structured format of
standardized intake assessment, personalized feedback of test results, and
follow-up interview to facilitate treatment outcome evaluation” (Lawendowski,
1998, p. A39).
The first multi-site trial of MET was Project MATCH, a nine-site trial with
1,726 clients. “Outcomes through three years of follow-up were found to be
similar for a four-session MET and two 12-session treatment methods with which
it was compared, yielding a cost-effectiveness advantage for MET” (Miller &
Rose, 2009, p. 529). However, Miller and Rose (2009) noted that not all trials
yielded positive results. Citing other studies, null findings were reported with
eating disorders, drug abuse and dependence, smoking, and problem drinking.
Clinician delivery of MI is a factor and not all participants respond positively to
MI-based therapy, and efficacy of MI may vary across populations, which
account for some of the null findings in trials. The authors stated, “Such variability
in outcomes across and within studies suggests the need to understand when
and how a treatment works and the conditions of delivery that may affect its
efficacy” (Miller & Rose, 2009, p.529).
While the authors raised some of concerns with MI such as the
relationship between therapist responses, client speech and subsequent
behavior change, discovering how therapist empathy actually affects client
outcomes and determining relational and technical components of MI, after 30
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years of research, “motivational interviewing is a psychotherapeutic model that is
evidence-based, relatively brief, specifiable, applicable across a wide variety of
problem areas, complementary to other active treatment methods, and learnable
by a broad range of helping professionals” (Miller & Rose, 2009, p. 535).
Using MI and/or MET provides an atmosphere that encourages individuals
in drug abuse treatment to look at the disconnect between where he or she is in
the stage of change continuum and to work toward targeted behavioral goals that
are achievable. The cookie cutter or one size fits all mentality that has been used
so often in treatment modalities is no longer refutable as a valid methodology for
successful treatment outcomes. A study conducted by Rohsenow, Monti, Martin,
Colby, Myers, Gulliver, Brown, Mueller, Gordon and Abrams (2004) provided
additional evidence of the effectiveness of MET. The study recruited 165
cocaine-dependent clients enrolled in daily substance abuse treatment in a
hospital setting that focused on learning theory and the 12-Step philosophy. The
study provided two sessions for cocaine-specific MET or a control condition of
meditation relaxation treatment (MRT) only during the first three days of a
treatment substance abuse treatment program. Patients met cocaine
dependence criteria according to the Structured Clinical Interview for DSM-IV,
patient version (1995) and to have used cocaine at least 10 days during the six
months before admission. Actively psychotic individuals and those who planned
to stay less than five weekdays were excluded from the study. Informed consent
forms were completed on the second day of the study and assessments were
done following recruitment, at discharge and again at three, six and 12 months
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post-discharge. Treatments consisted of 50-minute sessions every day, “with
individual sessions for two days followed by group sessions on subsequent days.
The study treatments replaced the program’s groups on functional analysis and
relapse prevention. Patients attended all other program activities (Rohsenow et
al., 2004, p. 864).
Using a Timeline Followback interview, which was given for six months
before treatment began and at each follow-up, assessed number of days of
cocaine, alcohol and other drug use and at every follow-up, urine specimens
were collected to determine drug use and a close friend or family member was
interviewed to corroborate the patient’s drug use or abstinence during this period.
“The Addiction Severity Index, 5th edition (ASI), which was given at pre-treatment
and at every follow-up was scored for the composite indices. For MET feedback,
some questions were repeated adding ‘as a result of your cocaine use’
(Rohsenow et al., 2004, p. 864).
For MET feedback, additional measures were completed by all patients
before randomization into the two study groups: Cocaine Effects Questionnaire
for Patient Populations, Cocaine Negative Consequences Checklist, Arithmetic
subtest of the Wechsler Adult Intelligence Scale-Revised, Logical Memory Test
of the Wechsler Memory Scale and Symbol Digit Modalities Test in addition to a
checklist of 10 medical consequences of cocaine, 12 route-specific
consequences, five pregnancy/fetal effects and four accident risk items were
administered. AIDS risk comprised 33 items regarding frequency of cocaine-
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related risky sexual behavior and risky drug use practices during the previous 30
days from the Risk Behavior Assessment (Rohsenow et al., 2004).
For MET, the initial session dealt with the patient’s understanding of the
pros and cons of their cocaine use, quitting cocaine, life goals and how cocaine
impacts achieving those goals, and their life one and 10 years from that point
with and without cocaine use. The second session reviewed their assessment
feedback as follows: “cocaine use relative to norms for cocaine abusers in
treatment and legal outcome, consequences identified by cocaine-modified ASI
questions and Cocaine Effects Questionnaire, neuropsychological functioning
(presented as five-point scales from well below average to well above average),
accident risk due to cocaine, medical complications from intoxication, withdrawal,
route, pregnancy and ASI items, and AIDS risk resulting from cocaine use. The
session closed with a summary, elicited reactions, built hope for improvement
through cessation, provided help with decision making and reinforced selfefficacy” (Rohsenow et al., 2004, p. 865-866).
MRT was selected because relaxation training is commonly used in
substance abuse treatment even though there is no scientific evidence to prove it
is effective with changing substance use. During the first minutes of each
session, patients were taught to focus on sensations such as warmth and
heaviness in each body part. Without interrupting the physical relaxation
sensation, patients were told to visualize a pleasing scene that did not include
drug use (Rohsenow et al., 2004).
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Following statistical analysis of the groups, it was found that “MET had
several beneficial treatment effects when provided at the start of an intensive
substance abuse treatment program for cocaine dependent patients, particularly
for those low in initial motivation to change cocaine use. Although low pretreatment motivation in the contrast condition predicted higher relapse to cocaine
in the first 3 months, patients in MET with low initial motivation reported lower
rates of relapse to alcohol at 4-6 months, less relapse to cocaine and alcohol at 1
year follow-up, fewer cocaine and alcohol use days during the year and less
sever alcohol problems than patients in MET with higher initial motivation to
change. Thus, MET appears to be more beneficial for less motivated patients
than for more motivated patients. Also, there was a significant time x treatment
interaction for employment problems; patients in MET tended to report a
decreasing severity of employment problems over the year of follow-up while
contrast patients did not” (Rohsenow et al, 2004, p. 872).
Statistical analyses were conducted to assess effects of individual
treatment with MET versus MRT and across other variables such as scoring on
the various instruments administered across the study. “An ANOVA showed
higher effectiveness rating for MET (M=6.2 ± 1.1) than MRT (M=5.8 ± 1.2),
F1.139=3.85, P<0.005, f=0.17 (small)” (Rohsenow et al., 2004, p. 871).
Despite study limitations, which included sample size, attrition, using a
private substance abuse program rather than a community based program and
using an intensive program versus less intensive outpatient programs, the
authors concluded that “programs that provide MET should probably provide it
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only to patients who are less motivated to change” and that “promise was shown
for the value of two sessions of MET early in treatment for cocaine abusers . . .”
(Rohsenow et al., 2004, p. 872).
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CHAPTER 6
FINDING ALTERNATE BEHAVIORS

Finding alternate behaviors when abstinence from one or more drugs is
achieved is paramount to prevent relapse. Moos (2006) noted, “Behavioral
economics or behavioral choice theory, which is closely related to the social
control perspective, focuses specifically on involvement in protective activities. In
behavioral choice theory the key element of the social context is the alternative
reinforcements provided by activities other than substance abuse. These
alternative reinforcements can protect individuals from exposure to substances
and opportunities to use them, as well as from escalating and maintaining
substance use. The theory posits that the choice of one reinforcing before, such
as substance use, depends in part on lack of effective access to alternative
reinforcements, such as involvement in school and work pursuits, religious
engagement, and participation in physical activity. For example, physical activity
and substance use may both elevate mood and decrease anxiety, which make
them functionally similar and substitutable” (Moos, 2006, p. 183).
Two behaviors frequently recommended to take the place of drug using
behavior are exercise and relaxation training (Urschell, 2009; Prentiss, 2007;
Peele & Brodsky, 1991; Bilodeau, 1992; Ratey, 2008). While both behaviors
have been proven as viable alternatives to drug using behaviors, this review will
focus on behavioral relaxation. Poppen (1988), following up on Edmund
Jacobsen’s original progressive relaxation model, posited a Behavioral
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Relaxation Scale (BRS) in order to measure relaxation to determine treatment
outcomes.
The BRS consists of ten postures and their coordinating observable
“relaxed” and “unrelaxed” states. The areas targeted for relaxation are: head,
eyes, mouth, throat, shoulders, body, hands, feet, quiet, and breathing. Poppen
noted, “The BRS has been shown to change in the expected direction when
people undergo relaxation training in the motoric domain, namely progressive
relaxation training (BRT), frontalis EMG biofeedback, and, of course BRT”
(Poppen, 1988, p. 45).
Depressive disorder is a common diagnosis with drug use. Whether it is
present prior to drug abuse or is a by-product of withdrawal from drug use,
depression and substance use often occur concurrently. Carpenter, Smith,
Ahdronovich and Nunes (2008) noted, “The relationship between environmental
contingencies and the course of depression and substance abuse suggests that
targeting environmental factors may be a particularly useful strategy for
simultaneously treating both disorders” (Carpenter, et al. 2008, p. 643). A
randomized trial of Behavioral Therapy for Depression in Drug Dependence
(BTDD) was compared to an attention control with Relaxation Therapy (REL)
selected as the control condition (Carpenter et al., 2008).
Of the 126 methadone-maintained opiate dependent candidates assessed
for inclusion in the study, 38 were accepted based on study inclusion criteria,
which included administration of the Structured Clinical Interview for DSM-IV
Substance Abuse Comorbidity, “current DSM-IV Major Depression or Dysthymic
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Disorder and a stable methadone dose (no changes in the prior two weeks) of 60
mg or greater; lower methadone doses were allowed if part of a slow methadone
taper following a successful maintenance period” (Carpenter et al., 2008, p. 643),
and completion of consent forms.
Depression severity was assessed at baseline and at the start of each
weekly session by one of the study’s trained and experienced clinicians using the
29-item Hamilton Depression Scale. Participants rated their depression using the
21-item Beck Depression Inventory II at baseline and bi-weekly during treatment.
At the beginning of each session, a clinician administered the Substance
Use Weekly Inventory to ascertain the number of days that opiates, cocaine,
alcohol, cannabis, sedative-hypnotics, stimulants and other substances were
used since the participant’s last session. Urine samples were collected weekly
under observation by a study staff member and were tested for opiates, cocaine
and benzodiazepines. Of the 533 urine samples collected, 370 had
corresponding self-reports for use the prior week; of those 370, “agreement
between toxicology results and self-reported use was 89% for opiates, 95% for
cocaine, and 94% for benzodiazepines” (Carpenter et al., 2008).
Participants were randomized to either one of two treatment conditions:
BTDD or REL stratified by antidepressant use at the time of study entry and illicit
drug use during the week prior to the start of the study. The BTDD section used
three operant-based treatments: changing reinforcement events, community
reinforcement approach and treatment plan contingency management program.

53
BTDD was administered over 24-weekly sessions and clinicians used a
structured treatment guide. Activities focused on improving the number and
quality of interactions participants experienced with their environments. At weekly
sessions, participants “defined objectively verifiable out-of-session activities to
increase the amount of pleasant activities in specified life areas” (Carpenter et
al., 2008, p. 645).
A Treatment Plan Contingency Management system was implemented
that gave points for actively participating in sessions (three points) and
completing out-of-session homework (10 points). Verification of out-of-session
homework was required by submitting movie ticket stubs, etc., and activities were
agreed to during the previous week’s session.
A total of 208 points were possible for 100% attendance (72 points) and
completion of all out-of-session homework (136 points). Voucher points equated
one dollar for each point and could be exchanged for goods and services
selected by the participant and in sync with treatment goals (Carpenter et al.,
2008).
REL was given across the 24-weekly sessions using a training manual.
REL incorporated four areas constituting successful therapies for depression: “a
clear rationale for treatment, provision of skills to help individuals become more
effective in handling his/her life, an emphasis on the use of these skills outside of
the therapy context, and reinforcing therapy success to use these skills”
(Carpenter et al., 2008, p. 645).
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The three relaxation methods covered were: progressive muscle
relaxation, autogenic relaxation exercises and visual imagery based on
idiographic scenarios of relaxation or tranquility. Participants used the techniques
during weekly sessions and were encouraged to track depression/anxiety during
the week and use relaxation exercises. All participants were told they could begin
taking medication if depression significantly worsened or they felt they had not
improved after six weeks of treatment.
Clinicians completed a BTDD or Relaxation Therapy Checklist, which
contained key areas of each treatment and how to access adherence to each
therapy condition, following every session (Carpenter et al., 2008).
The average depression ratings at the study’s end indicated a significant
decrease in self-reported and clinician rated depression during treatment;
however, the rate of change did not differ between treatment conditions.
Participants in BTDD earned approximately one-third of the maximum number of
voucher points that could be received. Among participants who received BTDD,
there was a significant increase in the probability of opiate use during treatment
after adjusting for adjunctive pharmacotherapy.
The significant reduction in depressive systems observed in both the
BTDD and REL conditions “supports the possible utility of both treatment
strategies in this population and suggests possible avenues for the continued
refinement of a behaviorally based treatment program for depression and
comorbid substance use in a methadone-maintained population” (Carpenter et
al., 2008., p. 649). The authors noted, “Relaxation training may offer an important
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therapeutic technique for treating depression among dually-diagnosed patients.
The acceptability of the treatment suggests that incorporating these techniques in
a comprehensive program may promote better attendance and engagement
compared to more demanding behavioral interventions” (Carpenter et al., 2008.,
p. 649).
Contingency management, however, may have been affected by the
presence of a depressive disorder and the authors concluded that vouchers “of a
larger magnitude that target both abstinence and treatment plan activities may
increase the effectiveness of this strategy for treating both depression and
comorbid substance use” (Carpenter et al., 2008, p. 650) and “focusing on
avoidance behaviors and placing change in the broader context of valued life
goals may provide a better strategy than focusing solely on increasing pleasant
activities” (Carpenter et al., 2008, p. 650).
The authors recognized several study limitations: small sample size and
significant attrition rate limited the power to detect group differences and
restricted generalizability to other populations; no control condition eliminated
equating the benefits of the study’s treatment conditions to the no treatment
condition; the BTDD condition had a higher proportion of opiate users, which may
have reduced the efficacy of BTDD relative to REL and could explain the
increase of opiate use over the course of the trial for BTDD participants
(Carpenter et al., 2008).
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CHAPTER 7
IS A “CURE” POSSIBLE?

Based on the research literature reviewed regarding drug addiction, there
is no “cure” per se, no magic bullet, no easy out. Drug addiction is a life-long
condition that may be managed through a willful dedication to change the
behaviors that resulted in dependence on crack cocaine or other substances.
Ongoing research, as presented here, is promising because it is evidence-based,
which makes it plausible as a viable avenue for change. Brain research,
particularly that which examines the chemical circuitry involved in naturally
occurring rewards and how drugs short-circuit and shutdown pathways, alters
cell content and consequently the ability to decide against drug taking behaviors,
is encouraging.
What if a vaccine were available, similar to measles or tetanus
vaccinations, that could eliminate the negative repercussions associated with
drug dependence? Anti-drug vaccines could train the immune system to destroy
a drug like cocaine before it reached the brain. But the brain does not operate
alone. “To accept the proposition of an addict’s powerlessness is to eliminate
volition from the equation, for we know from hard evidence that addicts can and
do kick the habit. And, no matter how difficult it eventually becomes to exercise
choice, there is always a period at the outset when choice is not only possible but
relatively easy,” according to Rosenthal (Rosenthal, 2008, p.43).
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In spite of its detractors, immunology studies are ongoing. To be effective,
anti-drug vaccines used to thwart the major drugs of abuse – nicotine, heroin,
cocaine and methamphetamine, need to produce “a high concentration of
antibodies with high affinity for the drug, would bind the drug molecule in the
circulation and prevent it from crossing the blood-brain barrier and accessing its
receptor in the brain” (Kinsey, Jackson & Orson, 2009, p. 309).
Thus far, anti-drug vaccines have shown promise when used in rodents,
“both in terms of the concentration of antibodies elicited by the vaccine and in the
reduction of drug associated behavior shown by vaccinated animals when
challenged with the drug” (Kinsey et al., 2009, p. 309).
A vaccine that would prevent cocaine from reaching the brain would be
beneficial in conjunction with behavior analysis and therapy. According to Kinsey
et al. (2009), the vaccine should have “few side effects, and should elicit high
levels of antibodies of good affinity after a reasonable delivery schedule” (Kinsey
et al., 2009, p. 311). The authors noted, “The approximate concentration of
cocaine in the blood after a session of smoking crack, for example, is well known,
and the concentration of anti-cocaine antibodies in vaccinated individuals is also
known. Comparing those numbers makes it evident that a person determined to
get a high from cocaine could easily just take more. That is why it is so essential
that anti-cocaine vaccination be accompanied by other forms of intervention,
such as drug counseling, to achieve a successful outcome for the addict” (Kinsey
et al., 2009, p. 311).
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Peterson and Owens (2009) reviewed research on the development of an
anti-drug vaccine for methamphetamine addiction. Like the Kinsey, et al,
research referenced above, the authors concurred that a vaccine alone is not the
answer. “Results from preclinical and clinical studies of active and passive
vaccines against drugs of abuse show promise as a viable medical approach to
treat addiction. However, antibody antagonists are not intended to be used as a
standalone ‘magic bullet’ to cure drug abuse. Similar to insulin treatment for
diabetic patients, they are likely best used in combination with a long-term
comprehensive medical approach. Thus, the next critical steps are to optimize
the therapeutic potential and timing of active or passive immunizations and to
couple these with a behavioral modification program aimed at helping patients
relearn constructive behaviors, impulse control, and resistance to the craving for
the drug” (Peterson & Owens, 1999, p. 122).
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CHAPTER 8
AT WHAT COST?

I loved the feeling of doing coke and heroin in a restaurant
bathroom because it was so sneaky. I had to walk into the
restaurant without anyone noticing, do my drugs, and walk out
again without getting caught. I loved the risk, the hidden identity
that I held, and the secret I was hiding. It made me feel a little like
James Bond.
(Prentiss, 2007, p. 108).
A study conducted by the RAND Corporation in 2005 estimated the cost to
the public for stimulant abuse to be $23 billion (Peterson & Owens, 2009). The
U.S. Department of Justice, National Drug Intelligence Center, National Drug
Threat Assessment 2010 (February 2010), reported, “The trafficking and abuse
of drugs in the United States affect nearly every aspect of our lives. The
economic cost alone is immense, estimated at nearly $215 billion. The damage
caused by drug abuse and addiction is reflected in an overburdened justice
system, a strained healthcare system, lost productivity, and environmental
destruction” (National Drug Threat Assessment, 2010).
Statistics supporting the payout of drugs from the National Drug Threat
Assessment referenced above follow:
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In 2008, approximately 2.9 million individuals tried an illicit drug or
used a prescription drug nonmedically for the first time,
representing 8,000 initiates per day.



In 2008, approximately 7 million individuals aged 12 and older were
dependent on or had abused illicit drugs in the past year, compared
with 6.9 million in 2007. The drugs with the highest dependence or
abuse levels were marijuana, prescription pain relievers, and
cocaine.



In 2006, the Drug Abuse Warning Network (DAWN) reported that of
113 million hospital ED visits, 1,742, 887 were related to drug
misuse or drug abuse. When drug misuse or abuse is reported in
ED visits, the most commonly reported substances are cocaine,
marijuana, heroin, and stimulants.



Due to drug abuse/dependence, in 2007, there were approximately
1.8 million admissions to state-licensed treatment facilities for illicit
drug use/dependence, meaning they were not gainfully employed.
In addition, in 2008 19.6% of unemployed adults were defined as
current users of illicit drugs; 8% of individuals employed full time
and 10.2% of individuals employed part-time were current users of
illicit drugs. People who are employed but have chronic
absenteeism from illicit drug use/abuse also have substantial lost
productivity.
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In 2009, in California alone, the California Department of Toxic
Substance Control responded to and cleaned up 232 laboratories
and dumpsites at a cost of $776,889 or roughly $3,349 per site.

According to the Office of National Drug Control Policy, Drug Policy
Information Clearing House regarding Illinois statistics:
 In 2002, there were 977 Illinois drug arrests by the Drug
Enforcement Administration (DEA).
 As of June 2005, approximately 25% of adult inmates in Illinois
were detained or incarcerated for drug offenses.
 In 2006, there were 996 drug arrests by the DEA and 112,368 state
and local (Chicago area) drug arrests.
 In 2006, it was reported that drug trafficking organizations based in
Mexico routinely transported metric ton quantities of cocaine into
Illinois, mainly Chicago.
 During 2006, 41% of Federally-sentenced defendants in Illinois had
committed a drug offense, of which one-third involved powder
cocaine.
 During 2006, there were 67,392 drug/alcohol treatment admissions
in Illinois.


As of April 2007, there were 20 drug courts in Illinois with eight
more planned for the near-term. As of 2009, there were 2,038
active drug court programs throughout the U.S. and 226 were in
the planning stages.
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Currently, the focus of the nation is not on the impact of drug dependence
on the economy, on our judicial and penal systems, on our healthcare system, on
treatment modalities that are more frequently unsuccessful than successful, on
the devastation to families who love someone addicted to drugs, etc.
An interesting, but unscientific, experiment is to ask co-workers, friends,
and acquaintances if they know anyone who is struggling with an addiction, not
including nicotine or caffeine. You may be surprised to find that the majority of
the people you query answer “yes.” Chances are they will relate experiences of
frustration, helplessness, and despair in trying to find a resolution to their friend
or loved one’s addiction.
It is true that there is no “magic bullet” to erase addiction from our human
condition. There has to be a concerted effort to change the tide of drugs coming
into the country and to address how illicit drugs work in our economy, from
providing a livelihood to pawnshop owners to corruption in law enforcement.
It will not be easy. It will take families of addicts who have lost their battle
with drugs to stand up and demand change. And to be strong enough to “tell it
like it is” to everyone who will listen. To stop being embarrassed or ashamed to
talk about the addiction of a son or daughter, husband or wife, mother or father.
It will take a grassroots movement similar to Mothers Against Drunk Drivers to
raise awareness about the waste of even one life to drugs.
There is significant evidence-based research, some of which has been
discussed in this paper, supporting substance abuse treatments that actually
may change the path of someone addicted to a substance. Addiction treatment
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professionals must start, if they do not already, to become familiar with this body
of research and additional studies and incorporate methodologies into their
practices. Treatment facilities have to be made accountable for the programs
provided and should be mandated to produce outcome statistics that are
reviewed by their board of directors and contributors and are part of staff
performance evaluations. Perhaps one way to instigate change would be to
include the costs associated with drug abuse and dependence in the country to
every tax payer in the U.S.
The question is who is going to start the revolution for change?
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